Highlights
NASDAQ: GLPG       Galapagos NV
Last Price Today's Change   Day's Range   Trading Volume
172.18   +2.61 (1.54%)  170.76 - 172.55  212,200

Overview

 
Avg Volume (4 weeks):156,865
4 Weeks Range:168.54 - 191.63
4 Weeks Price Volatility (%):
15.76%
52 Weeks Range:85.00 - 191.63
52 Weeks Price Volatility (%):
81.76%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Galapagos is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company’s product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

  Be the first to like this.
 


 

5864  1992  545  448 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GE 8.79+0.78 
 SPY 288.85+4.20 
 AMD 31.18+1.51 
 BAC 27.03+0.78 
 GDX 28.28-0.45 
 EEM 39.54+0.54 
 XLF 26.57+0.46 
 QQQ 185.48+2.93 
 TVIX 19.79-2.37 
 CHK 1.39+0.10 
Partners & Brokers